|
Fusion gene ID: 34297 |
FusionGeneSummary for SLC2A13_FAM120A |
Fusion gene summary |
Fusion gene information | Fusion gene name: SLC2A13_FAM120A | Fusion gene ID: 34297 | Hgene | Tgene | Gene symbol | SLC2A13 | FAM120A | Gene ID | 114134 | 23196 |
Gene name | solute carrier family 2 member 13 | family with sequence similarity 120A | |
Synonyms | HMIT | C9orf10|HBVPTPAP|OSSA | |
Cytomap | 12q12 | 9q22.31 | |
Type of gene | protein-coding | protein-coding | |
Description | proton myo-inositol cotransporterH(+)-myo-inositol symporterh(+)-myo-inositol cotransporterproton (H+) myo-inositol symportersolute carrier family 2 (facilitated glucose transporter), member 13 | constitutive coactivator of PPAR-gamma-like protein 1oxidative stess-associated Src activatoroxidative stress-associated Src activator | |
Modification date | 20180523 | 20180523 | |
UniProtAcc | Q96QE2 | Q9NZB2 | |
Ensembl transtripts involved in fusion gene | ENST00000280871, ENST00000380858, | ENST00000277165, ENST00000375389, ENST00000340893, ENST00000333936, ENST00000475933, | |
Fusion gene scores | * DoF score | 9 X 5 X 7=315 | 3 X 3 X 3=27 |
# samples | 7 | 3 | |
** MAII score | log2(7/315*10)=-2.16992500144231 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/27*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: SLC2A13 [Title/Abstract] AND FAM120A [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | BLCA | TCGA-CU-A0YN-01A | SLC2A13 | chr12 | 40422103 | - | FAM120A | chr9 | 96323391 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000280871 | ENST00000277165 | SLC2A13 | chr12 | 40422103 | - | FAM120A | chr9 | 96323391 | + |
5CDS-intron | ENST00000280871 | ENST00000375389 | SLC2A13 | chr12 | 40422103 | - | FAM120A | chr9 | 96323391 | + |
5CDS-intron | ENST00000280871 | ENST00000340893 | SLC2A13 | chr12 | 40422103 | - | FAM120A | chr9 | 96323391 | + |
5CDS-intron | ENST00000280871 | ENST00000333936 | SLC2A13 | chr12 | 40422103 | - | FAM120A | chr9 | 96323391 | + |
5CDS-intron | ENST00000280871 | ENST00000475933 | SLC2A13 | chr12 | 40422103 | - | FAM120A | chr9 | 96323391 | + |
In-frame | ENST00000380858 | ENST00000277165 | SLC2A13 | chr12 | 40422103 | - | FAM120A | chr9 | 96323391 | + |
5CDS-intron | ENST00000380858 | ENST00000375389 | SLC2A13 | chr12 | 40422103 | - | FAM120A | chr9 | 96323391 | + |
5CDS-intron | ENST00000380858 | ENST00000340893 | SLC2A13 | chr12 | 40422103 | - | FAM120A | chr9 | 96323391 | + |
5CDS-intron | ENST00000380858 | ENST00000333936 | SLC2A13 | chr12 | 40422103 | - | FAM120A | chr9 | 96323391 | + |
5CDS-intron | ENST00000380858 | ENST00000475933 | SLC2A13 | chr12 | 40422103 | - | FAM120A | chr9 | 96323391 | + |
Top |
FusionProtFeatures for SLC2A13_FAM120A |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
SLC2A13 | FAM120A |
H(+)-myo-inositol cotransporter. Can also transportrelated stereoisomers. {ECO:0000269|PubMed:11500374}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | SLC2A13 | chr12:40422103 | chr9:96323391 | ENST00000280871 | - | 3 | 10 | 147_148 | 308 | 649 | Topological domain | Cytoplasmic |
Hgene | SLC2A13 | chr12:40422103 | chr9:96323391 | ENST00000280871 | - | 3 | 10 | 170_178 | 308 | 649 | Topological domain | Extracellular |
Hgene | SLC2A13 | chr12:40422103 | chr9:96323391 | ENST00000280871 | - | 3 | 10 | 1_76 | 308 | 649 | Topological domain | Cytoplasmic |
Hgene | SLC2A13 | chr12:40422103 | chr9:96323391 | ENST00000280871 | - | 3 | 10 | 200_212 | 308 | 649 | Topological domain | Cytoplasmic |
Hgene | SLC2A13 | chr12:40422103 | chr9:96323391 | ENST00000280871 | - | 3 | 10 | 234_239 | 308 | 649 | Topological domain | Extracellular |
Hgene | SLC2A13 | chr12:40422103 | chr9:96323391 | ENST00000280871 | - | 3 | 10 | 98_125 | 308 | 649 | Topological domain | Extracellular |
Hgene | SLC2A13 | chr12:40422103 | chr9:96323391 | ENST00000280871 | - | 3 | 10 | 126_146 | 308 | 649 | Transmembrane | Helical%3B Name%3D2 |
Hgene | SLC2A13 | chr12:40422103 | chr9:96323391 | ENST00000280871 | - | 3 | 10 | 149_169 | 308 | 649 | Transmembrane | Helical%3B Name%3D3 |
Hgene | SLC2A13 | chr12:40422103 | chr9:96323391 | ENST00000280871 | - | 3 | 10 | 179_199 | 308 | 649 | Transmembrane | Helical%3B Name%3D4 |
Hgene | SLC2A13 | chr12:40422103 | chr9:96323391 | ENST00000280871 | - | 3 | 10 | 213_233 | 308 | 649 | Transmembrane | Helical%3B Name%3D5 |
Hgene | SLC2A13 | chr12:40422103 | chr9:96323391 | ENST00000280871 | - | 3 | 10 | 240_260 | 308 | 649 | Transmembrane | Helical%3B Name%3D6 |
Hgene | SLC2A13 | chr12:40422103 | chr9:96323391 | ENST00000280871 | - | 3 | 10 | 77_97 | 308 | 649 | Transmembrane | Helical%3B Name%3D1 |
Tgene | >FAM120A | chr12:40422103 | chr9:96323391 | ENST00000375389 | + | 0 | 9 | 829_1118 | -9 | 629 | Region | Note=RNA binding |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | >SLC2A13 | chr12:40422103 | chr9:96323391 | ENST00000280871 | - | 3 | 10 | 261_324 | 308 | 649 | Topological domain | Cytoplasmic |
Hgene | >SLC2A13 | chr12:40422103 | chr9:96323391 | ENST00000280871 | - | 3 | 10 | 346_363 | 308 | 649 | Topological domain | Extracellular |
Hgene | >SLC2A13 | chr12:40422103 | chr9:96323391 | ENST00000280871 | - | 3 | 10 | 385_393 | 308 | 649 | Topological domain | Cytoplasmic |
Hgene | >SLC2A13 | chr12:40422103 | chr9:96323391 | ENST00000280871 | - | 3 | 10 | 415_508 | 308 | 649 | Topological domain | Extracellular |
Hgene | >SLC2A13 | chr12:40422103 | chr9:96323391 | ENST00000280871 | - | 3 | 10 | 530_549 | 308 | 649 | Topological domain | Cytoplasmic |
Hgene | >SLC2A13 | chr12:40422103 | chr9:96323391 | ENST00000280871 | - | 3 | 10 | 571_573 | 308 | 649 | Topological domain | Extracellular |
Hgene | >SLC2A13 | chr12:40422103 | chr9:96323391 | ENST00000280871 | - | 3 | 10 | 595_648 | 308 | 649 | Topological domain | Cytoplasmic |
Hgene | >SLC2A13 | chr12:40422103 | chr9:96323391 | ENST00000280871 | - | 3 | 10 | 325_345 | 308 | 649 | Transmembrane | Helical%3B Name%3D7 |
Hgene | >SLC2A13 | chr12:40422103 | chr9:96323391 | ENST00000280871 | - | 3 | 10 | 364_384 | 308 | 649 | Transmembrane | Helical%3B Name%3D8 |
Hgene | >SLC2A13 | chr12:40422103 | chr9:96323391 | ENST00000280871 | - | 3 | 10 | 394_414 | 308 | 649 | Transmembrane | Helical%3B Name%3D9 |
Hgene | >SLC2A13 | chr12:40422103 | chr9:96323391 | ENST00000280871 | - | 3 | 10 | 509_529 | 308 | 649 | Transmembrane | Helical%3B Name%3D10 |
Hgene | >SLC2A13 | chr12:40422103 | chr9:96323391 | ENST00000280871 | - | 3 | 10 | 550_570 | 308 | 649 | Transmembrane | Helical%3B Name%3D11 |
Hgene | >SLC2A13 | chr12:40422103 | chr9:96323391 | ENST00000280871 | - | 3 | 10 | 574_594 | 308 | 649 | Transmembrane | Helical%3B Name%3D12 |
Tgene | FAM120A | chr12:40422103 | chr9:96323391 | ENST00000277165 | + | 14 | 18 | 829_1118 | 935 | 1119 | Region | Note=RNA binding |
Tgene | FAM120A | chr12:40422103 | chr9:96323391 | ENST00000333936 | + | 15 | 19 | 829_1118 | 963 | 1147 | Region | Note=RNA binding |
Tgene | FAM120A | chr12:40422103 | chr9:96323391 | ENST00000340893 | + | 13 | 17 | 829_1118 | 889 | 1073 | Region | Note=RNA binding |
Top |
FusionGeneSequence for SLC2A13_FAM120A |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
>In-frame_SLC2A13_ENST00000280871_chr12_40422103_-_FAM120A_ENST00000277165_chr9_96323391_+_492aa MSRKASENVEYTLRSLSSLMGERRRKQPEPDAASAAGECSLLAAAESSTSLQSAGAGGGGVGDLERAARRQFQQDETPAFVYVVAVFSAL GGFLFGYDTGVVSGAMLLLKRQLSLDALWQELLVSSTVGAAAVSALAGGALNGVFGRRAAILLASALFTAGSAVLAAANNKETLLAGRLV VGLGIGIASMTVPVYIAEVSPPNLRGRLVTINTLFITGGQFFASVVDGAFSYLQKDGWRYMLGLAAVPAVIQFFGFLFLPESPRWLIQKG QTQKARRILSQMRGNQTIDEEYDSIKNNIEEEEKEVGSGVQPIPSQGGKLEIAGTVVGHWAGSRRGRGGRGPFPLQVVSVGGPARGRPRG VISTPVIRTFGRGGRYYGRGYKNQAAIQGRPPYAASAEEVAKELKSKSGESKSSAMSSDGSLAENGVMAEEKPAPQMNGSTGDARAPSHS >In-frame_SLC2A13_ENST00000380858_chr12_40422103_-_FAM120A_ENST00000277165_chr9_96323391_+_492aa MSRKASENVEYTLRSLSSLMGERRRKQPEPDAASAAGECSLLAAAESSTSLQSAGAGGGGVGDLERAARRQFQQDETPAFVYVVAVFSAL GGFLFGYDTGVVSGAMLLLKRQLSLDALWQELLVSSTVGAAAVSALAGGALNGVFGRRAAILLASALFTAGSAVLAAANNKETLLAGRLV VGLGIGIASMTVPVYIAEVSPPNLRGRLVTINTLFITGGQFFASVVDGAFSYLQKDGWRYMLGLAAVPAVIQFFGFLFLPESPRWLIQKG QTQKARRILSQMRGNQTIDEEYDSIKNNIEEEEKEVGSGVQPIPSQGGKLEIAGTVVGHWAGSRRGRGGRGPFPLQVVSVGGPARGRPRG VISTPVIRTFGRGGRYYGRGYKNQAAIQGRPPYAASAEEVAKELKSKSGESKSSAMSSDGSLAENGVMAEEKPAPQMNGSTGDARAPSHS |
* Fusion transcript sequences (only coding sequence (CDS) region). |
>In-frame_SLC2A13_ENST00000280871_chr12_40422103_-_FAM120A_ENST00000277165_chr9_96323391_+_1476nt ATGTCCCGCAAGGCAAGCGAGAATGTGGAGTACACGCTGCGGAGCCTGAGCAGCCTGATGGGCGAGCGGCGCAGGAAGCAGCCGGAGCCG GACGCGGCGAGCGCGGCCGGGGAGTGCAGCCTCCTGGCTGCCGCCGAATCGAGCACCAGCCTGCAGAGCGCGGGCGCGGGCGGCGGCGGC GTCGGGGACCTGGAGCGCGCGGCGCGGCGGCAGTTCCAGCAGGACGAGACCCCCGCCTTCGTGTACGTGGTGGCCGTCTTCTCCGCGCTG GGCGGCTTCCTGTTTGGCTATGACACCGGGGTGGTGTCAGGGGCCATGCTGCTGCTCAAGCGGCAGCTCAGTCTGGACGCGCTGTGGCAG GAGCTGCTGGTGTCCAGCACGGTGGGGGCGGCTGCCGTCTCGGCGCTGGCCGGAGGCGCCCTCAACGGCGTCTTCGGCCGCCGCGCTGCC ATCCTCCTGGCCAGTGCCCTCTTCACCGCCGGCTCCGCGGTGCTGGCTGCGGCCAACAACAAGGAGACACTGCTCGCCGGCCGCCTGGTC GTGGGACTCGGCATCGGCATTGCTTCTATGACAGTGCCAGTGTACATTGCGGAGGTCTCACCACCCAATTTAAGAGGCCGATTAGTCACC ATTAATACCCTCTTCATCACAGGAGGGCAGTTCTTTGCAAGTGTTGTTGATGGAGCCTTCAGTTATCTCCAGAAGGATGGATGGAGGTAC ATGTTGGGACTTGCAGCAGTTCCGGCGGTTATACAGTTTTTTGGCTTTCTCTTTTTGCCTGAAAGCCCTCGATGGCTTATTCAGAAAGGA CAGACTCAGAAGGCCCGTAGAATTTTATCTCAGATGCGTGGTAACCAGACCATTGATGAGGAATATGATAGCATCAAAAACAACATTGAA GAGGAGGAAAAAGAGGTTGGCTCAGGAGTCCAACCTATACCTTCTCAGGGAGGCAAACTAGAAATAGCTGGCACTGTGGTTGGCCATTGG GCTGGGAGCAGGCGGGGCCGTGGGGGCCGGGGGCCTTTCCCCCTGCAGGTGGTTTCTGTCGGAGGACCAGCTAGAGGGCGTCCAAGAGGA GTTATTTCCACCCCAGTGATTAGAACATTTGGAAGAGGTGGAAGGTACTATGGCAGAGGTTACAAAAACCAGGCAGCAATTCAGGGCAGA CCTCCTTATGCTGCTTCAGCAGAAGAAGTGGCCAAAGAACTTAAGTCAAAATCTGGGGAATCGAAGTCCTCTGCTATGTCTTCAGACGGG TCCCTGGCTGAAAACGGAGTGATGGCCGAGGAGAAGCCGGCTCCCCAGATGAACGGGAGCACGGGTGACGCCAGGGCCCCCAGCCACTCT GAAAGTGCCTTGAATAATGACTCTAAAACGTGCAATACAAATCCTCATTTAAATGCACTAAGTACAGACAGCGCTTGCCGCAGAGAAGCT >In-frame_SLC2A13_ENST00000380858_chr12_40422103_-_FAM120A_ENST00000277165_chr9_96323391_+_1476nt ATGTCCCGCAAGGCAAGCGAGAATGTGGAGTACACGCTGCGGAGCCTGAGCAGCCTGATGGGCGAGCGGCGCAGGAAGCAGCCGGAGCCG GACGCGGCGAGCGCGGCCGGGGAGTGCAGCCTCCTGGCTGCCGCCGAATCGAGCACCAGCCTGCAGAGCGCGGGCGCGGGCGGCGGCGGC GTCGGGGACCTGGAGCGCGCGGCGCGGCGGCAGTTCCAGCAGGACGAGACCCCCGCCTTCGTGTACGTGGTGGCCGTCTTCTCCGCGCTG GGCGGCTTCCTGTTTGGCTATGACACCGGGGTGGTGTCAGGGGCCATGCTGCTGCTCAAGCGGCAGCTCAGTCTGGACGCGCTGTGGCAG GAGCTGCTGGTGTCCAGCACGGTGGGGGCGGCTGCCGTCTCGGCGCTGGCCGGAGGCGCCCTCAACGGCGTCTTCGGCCGCCGCGCTGCC ATCCTCCTGGCCAGTGCCCTCTTCACCGCCGGCTCCGCGGTGCTGGCTGCGGCCAACAACAAGGAGACACTGCTCGCCGGCCGCCTGGTC GTGGGACTCGGCATCGGCATTGCTTCTATGACAGTGCCAGTGTACATTGCGGAGGTCTCACCACCCAATTTAAGAGGCCGATTAGTCACC ATTAATACCCTCTTCATCACAGGAGGGCAGTTCTTTGCAAGTGTTGTTGATGGAGCCTTCAGTTATCTCCAGAAGGATGGATGGAGGTAC ATGTTGGGACTTGCAGCAGTTCCGGCGGTTATACAGTTTTTTGGCTTTCTCTTTTTGCCTGAAAGCCCTCGATGGCTTATTCAGAAAGGA CAGACTCAGAAGGCCCGTAGAATTTTATCTCAGATGCGTGGTAACCAGACCATTGATGAGGAATATGATAGCATCAAAAACAACATTGAA GAGGAGGAAAAAGAGGTTGGCTCAGGAGTCCAACCTATACCTTCTCAGGGAGGCAAACTAGAAATAGCTGGCACTGTGGTTGGCCATTGG GCTGGGAGCAGGCGGGGCCGTGGGGGCCGGGGGCCTTTCCCCCTGCAGGTGGTTTCTGTCGGAGGACCAGCTAGAGGGCGTCCAAGAGGA GTTATTTCCACCCCAGTGATTAGAACATTTGGAAGAGGTGGAAGGTACTATGGCAGAGGTTACAAAAACCAGGCAGCAATTCAGGGCAGA CCTCCTTATGCTGCTTCAGCAGAAGAAGTGGCCAAAGAACTTAAGTCAAAATCTGGGGAATCGAAGTCCTCTGCTATGTCTTCAGACGGG TCCCTGGCTGAAAACGGAGTGATGGCCGAGGAGAAGCCGGCTCCCCAGATGAACGGGAGCACGGGTGACGCCAGGGCCCCCAGCCACTCT GAAAGTGCCTTGAATAATGACTCTAAAACGTGCAATACAAATCCTCATTTAAATGCACTAAGTACAGACAGCGCTTGCCGCAGAGAAGCT |
* Fusion transcript sequences (Full-length transcript). |
>In-frame_SLC2A13_ENST00000280871_chr12_40422103_-_FAM120A_ENST00000277165_chr9_96323391_+_3094nt CTGCCGGCCCGCGGAGCCGCGTCCCCCCGGGCAGCCCCGGGCCCCTGCCCTATGTCCCGCAAGGCAAGCGAGAATGTGGAGTACACGCTG CGGAGCCTGAGCAGCCTGATGGGCGAGCGGCGCAGGAAGCAGCCGGAGCCGGACGCGGCGAGCGCGGCCGGGGAGTGCAGCCTCCTGGCT GCCGCCGAATCGAGCACCAGCCTGCAGAGCGCGGGCGCGGGCGGCGGCGGCGTCGGGGACCTGGAGCGCGCGGCGCGGCGGCAGTTCCAG CAGGACGAGACCCCCGCCTTCGTGTACGTGGTGGCCGTCTTCTCCGCGCTGGGCGGCTTCCTGTTTGGCTATGACACCGGGGTGGTGTCA GGGGCCATGCTGCTGCTCAAGCGGCAGCTCAGTCTGGACGCGCTGTGGCAGGAGCTGCTGGTGTCCAGCACGGTGGGGGCGGCTGCCGTC TCGGCGCTGGCCGGAGGCGCCCTCAACGGCGTCTTCGGCCGCCGCGCTGCCATCCTCCTGGCCAGTGCCCTCTTCACCGCCGGCTCCGCG GTGCTGGCTGCGGCCAACAACAAGGAGACACTGCTCGCCGGCCGCCTGGTCGTGGGACTCGGCATCGGCATTGCTTCTATGACAGTGCCA GTGTACATTGCGGAGGTCTCACCACCCAATTTAAGAGGCCGATTAGTCACCATTAATACCCTCTTCATCACAGGAGGGCAGTTCTTTGCA AGTGTTGTTGATGGAGCCTTCAGTTATCTCCAGAAGGATGGATGGAGGTACATGTTGGGACTTGCAGCAGTTCCGGCGGTTATACAGTTT TTTGGCTTTCTCTTTTTGCCTGAAAGCCCTCGATGGCTTATTCAGAAAGGACAGACTCAGAAGGCCCGTAGAATTTTATCTCAGATGCGT GGTAACCAGACCATTGATGAGGAATATGATAGCATCAAAAACAACATTGAAGAGGAGGAAAAAGAGGTTGGCTCAGGAGTCCAACCTATA CCTTCTCAGGGAGGCAAACTAGAAATAGCTGGCACTGTGGTTGGCCATTGGGCTGGGAGCAGGCGGGGCCGTGGGGGCCGGGGGCCTTTC CCCCTGCAGGTGGTTTCTGTCGGAGGACCAGCTAGAGGGCGTCCAAGAGGAGTTATTTCCACCCCAGTGATTAGAACATTTGGAAGAGGT GGAAGGTACTATGGCAGAGGTTACAAAAACCAGGCAGCAATTCAGGGCAGACCTCCTTATGCTGCTTCAGCAGAAGAAGTGGCCAAAGAA CTTAAGTCAAAATCTGGGGAATCGAAGTCCTCTGCTATGTCTTCAGACGGGTCCCTGGCTGAAAACGGAGTGATGGCCGAGGAGAAGCCG GCTCCCCAGATGAACGGGAGCACGGGTGACGCCAGGGCCCCCAGCCACTCTGAAAGTGCCTTGAATAATGACTCTAAAACGTGCAATACA AATCCTCATTTAAATGCACTAAGTACAGACAGCGCTTGCCGCAGAGAAGCTGCTCTGGAGGCAGCTGTCTTAAATAAAGAAGAGTAAACT TATTTTTTATAGAGGGTGAAGGATGCTGGAAGGGTAAGGATTTAGGAATATCTGGAGAGAAAGAGAGCCTGCAGTTATGTACATTTTGTC CTTTCCGTAAGAGAAAAATGAGGACTTTGGAAATTCAGATCCCTCTTTGATATCAGAGATTTAAACAACACATTTTTAGTTTTAACCAGT TGTAGTCAAAATGCTACAATAAAACAAAAAAGAGAAAGAAAATGAAGAGCATTTGACTCCCGCACTTAAAATGAAGTACACATAAAGTTT AAACTGGTTATGACAAAAGCCTTTAGTTGTGTTTCTTGAACTATAAAGAAAACAAATTTTGGCAGTCTTTAAGTATATATAGCTTAAAAT ATAATTTTTAGCATTTGGCACCATATGTATGCCATTATATTTGATTTTGCATTACTGTTTCACAATGAAGCTTTCTTTAAGGCTTTGATT TTTATGATTATGAAAGAAATAAGGCACAACCACAGTTTTTCTTTCTTAAATTTCATCACTGTTGATGTGGTTCTTTTGTGTTAAAAAAAA AAAGTGCAACTATCAAAACTAAAAAATTATAGAGTAATATTGCCGTTCTGCTGATTTTAAATATACAATACATCATACATACTTTACAAG CAAGTTAAATGGAGATAAAGTTGAAATCATAGAAGATGCAAATGACCTTTCAAAATCAACACAATGTGTTCTGAAACTTTCGTGACTAAT ACCATGCATCTGTGATCAATGAACTATGTGGTTTTGAATCGGATGTAGACCATTAGTACTACTACTTGAGCTAAACTTCTGCATGGTTCA TAATTTTTAAAGTGTGTAGTTAATATGCATGTTATCGTCCTTTCTTCCATTCTTAACAGTATGTGCCCATTTGCAAAACAAAAATGCTAA TAATCAGTAATAGTCCTATAAAAGATGTTAACTCTGTTTAGTCATTGACTGATCTTGCTCTAACCTTAAAATTTTGTGATTATTGACCTC TGTTGCATTTATTCTAAAGCCCCCCAAAAATTATCTAGCCGTTTCGAATATCAACATTACCCTGGTGTATTCACTGCTGTATGCATTATT GTTCTTTGTTGCTGTTTTATGCCTTCATATTAGCAAATATGAAATTCTGTGAAAAAAAACCCTTTGATCTTAAAAAAAAAAAAACCACCC CCCCCTTCTGTAGCAGGAAACAAATTGCTTGTTCTTGAGAACTTTCCCATCAAGAATTTAGTAGAAGCAGGTATACTTCTATCATTTTGA TGTTTTTGTTAATGTTTCCAAACAATGTACTTTGAAATCAGAATCACTTCTTATCGTTTTCATATACTTCTGATGCTCTTCATCACATTA GTGATCAGAAATGAGGTGTAATTCCCCAACCCCTGCCCGCAAGAGCTAAGTAGGATCTTACTGTAAGTTGAAGGGAGTTTTGCCCTAACT CATGGATTGTGCAAGAATGAACTGCTGTTGGGTTTGATTGACTGTCGATGGATTGTGGTGTGGTGTATCTGAAGGCTATTGAATGCAACT >In-frame_SLC2A13_ENST00000380858_chr12_40422103_-_FAM120A_ENST00000277165_chr9_96323391_+_3324nt CGCCTCCCGCCCGCTCCGCAGCGCCAGCTCGGCAGGCGCGGGGCGTGAGTGTGGAGTGAGACCCGCCGGGCTCCAACTCCGCAGCGTCGG AGCGCGGCGGGCAGCAACTTTCTCCCCGGAGCGGCCGTGGCGGCGGCTGCTGCCGTGGCAGCCGGAGCGGAAGCCGGGAGGAAGAAAGCG GCGGCAGCGGCGGTTGCTCCCGCCGGCTCGGGCTGTCTAGCTCGCCGAGACTGCCGGCCCGCGGAGCCGCGTCCCCCCGGGCAGCCCCGG GCCCCTGCCCTATGTCCCGCAAGGCAAGCGAGAATGTGGAGTACACGCTGCGGAGCCTGAGCAGCCTGATGGGCGAGCGGCGCAGGAAGC AGCCGGAGCCGGACGCGGCGAGCGCGGCCGGGGAGTGCAGCCTCCTGGCTGCCGCCGAATCGAGCACCAGCCTGCAGAGCGCGGGCGCGG GCGGCGGCGGCGTCGGGGACCTGGAGCGCGCGGCGCGGCGGCAGTTCCAGCAGGACGAGACCCCCGCCTTCGTGTACGTGGTGGCCGTCT TCTCCGCGCTGGGCGGCTTCCTGTTTGGCTATGACACCGGGGTGGTGTCAGGGGCCATGCTGCTGCTCAAGCGGCAGCTCAGTCTGGACG CGCTGTGGCAGGAGCTGCTGGTGTCCAGCACGGTGGGGGCGGCTGCCGTCTCGGCGCTGGCCGGAGGCGCCCTCAACGGCGTCTTCGGCC GCCGCGCTGCCATCCTCCTGGCCAGTGCCCTCTTCACCGCCGGCTCCGCGGTGCTGGCTGCGGCCAACAACAAGGAGACACTGCTCGCCG GCCGCCTGGTCGTGGGACTCGGCATCGGCATTGCTTCTATGACAGTGCCAGTGTACATTGCGGAGGTCTCACCACCCAATTTAAGAGGCC GATTAGTCACCATTAATACCCTCTTCATCACAGGAGGGCAGTTCTTTGCAAGTGTTGTTGATGGAGCCTTCAGTTATCTCCAGAAGGATG GATGGAGGTACATGTTGGGACTTGCAGCAGTTCCGGCGGTTATACAGTTTTTTGGCTTTCTCTTTTTGCCTGAAAGCCCTCGATGGCTTA TTCAGAAAGGACAGACTCAGAAGGCCCGTAGAATTTTATCTCAGATGCGTGGTAACCAGACCATTGATGAGGAATATGATAGCATCAAAA ACAACATTGAAGAGGAGGAAAAAGAGGTTGGCTCAGGAGTCCAACCTATACCTTCTCAGGGAGGCAAACTAGAAATAGCTGGCACTGTGG TTGGCCATTGGGCTGGGAGCAGGCGGGGCCGTGGGGGCCGGGGGCCTTTCCCCCTGCAGGTGGTTTCTGTCGGAGGACCAGCTAGAGGGC GTCCAAGAGGAGTTATTTCCACCCCAGTGATTAGAACATTTGGAAGAGGTGGAAGGTACTATGGCAGAGGTTACAAAAACCAGGCAGCAA TTCAGGGCAGACCTCCTTATGCTGCTTCAGCAGAAGAAGTGGCCAAAGAACTTAAGTCAAAATCTGGGGAATCGAAGTCCTCTGCTATGT CTTCAGACGGGTCCCTGGCTGAAAACGGAGTGATGGCCGAGGAGAAGCCGGCTCCCCAGATGAACGGGAGCACGGGTGACGCCAGGGCCC CCAGCCACTCTGAAAGTGCCTTGAATAATGACTCTAAAACGTGCAATACAAATCCTCATTTAAATGCACTAAGTACAGACAGCGCTTGCC GCAGAGAAGCTGCTCTGGAGGCAGCTGTCTTAAATAAAGAAGAGTAAACTTATTTTTTATAGAGGGTGAAGGATGCTGGAAGGGTAAGGA TTTAGGAATATCTGGAGAGAAAGAGAGCCTGCAGTTATGTACATTTTGTCCTTTCCGTAAGAGAAAAATGAGGACTTTGGAAATTCAGAT CCCTCTTTGATATCAGAGATTTAAACAACACATTTTTAGTTTTAACCAGTTGTAGTCAAAATGCTACAATAAAACAAAAAAGAGAAAGAA AATGAAGAGCATTTGACTCCCGCACTTAAAATGAAGTACACATAAAGTTTAAACTGGTTATGACAAAAGCCTTTAGTTGTGTTTCTTGAA CTATAAAGAAAACAAATTTTGGCAGTCTTTAAGTATATATAGCTTAAAATATAATTTTTAGCATTTGGCACCATATGTATGCCATTATAT TTGATTTTGCATTACTGTTTCACAATGAAGCTTTCTTTAAGGCTTTGATTTTTATGATTATGAAAGAAATAAGGCACAACCACAGTTTTT CTTTCTTAAATTTCATCACTGTTGATGTGGTTCTTTTGTGTTAAAAAAAAAAAGTGCAACTATCAAAACTAAAAAATTATAGAGTAATAT TGCCGTTCTGCTGATTTTAAATATACAATACATCATACATACTTTACAAGCAAGTTAAATGGAGATAAAGTTGAAATCATAGAAGATGCA AATGACCTTTCAAAATCAACACAATGTGTTCTGAAACTTTCGTGACTAATACCATGCATCTGTGATCAATGAACTATGTGGTTTTGAATC GGATGTAGACCATTAGTACTACTACTTGAGCTAAACTTCTGCATGGTTCATAATTTTTAAAGTGTGTAGTTAATATGCATGTTATCGTCC TTTCTTCCATTCTTAACAGTATGTGCCCATTTGCAAAACAAAAATGCTAATAATCAGTAATAGTCCTATAAAAGATGTTAACTCTGTTTA GTCATTGACTGATCTTGCTCTAACCTTAAAATTTTGTGATTATTGACCTCTGTTGCATTTATTCTAAAGCCCCCCAAAAATTATCTAGCC GTTTCGAATATCAACATTACCCTGGTGTATTCACTGCTGTATGCATTATTGTTCTTTGTTGCTGTTTTATGCCTTCATATTAGCAAATAT GAAATTCTGTGAAAAAAAACCCTTTGATCTTAAAAAAAAAAAAACCACCCCCCCCTTCTGTAGCAGGAAACAAATTGCTTGTTCTTGAGA ACTTTCCCATCAAGAATTTAGTAGAAGCAGGTATACTTCTATCATTTTGATGTTTTTGTTAATGTTTCCAAACAATGTACTTTGAAATCA GAATCACTTCTTATCGTTTTCATATACTTCTGATGCTCTTCATCACATTAGTGATCAGAAATGAGGTGTAATTCCCCAACCCCTGCCCGC AAGAGCTAAGTAGGATCTTACTGTAAGTTGAAGGGAGTTTTGCCCTAACTCATGGATTGTGCAAGAATGAACTGCTGTTGGGTTTGATTG |
Top |
FusionGenePPI for SLC2A13_FAM120A |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
SLC2A13 | FAM120A | SIRT7, CUL3, CAND1, GRK5, CFTR, TARDBP, HECW2, PASK, STAU1, SPRTN, CEP250, NXF1, EZH2, RNF2, BMI1, FBXW11, EFNB2, GGPS1, HNRNPA1, PRMT8, ILF2, RBMX, SPACA4, IFI30, NTRK1, SSX2IP, HNRNPD, HNRNPH2, HNRNPU, MATR3, SEC16A, SYNCRIP, MRPL50, ATL2, FOXK2, FOXQ1, ZNF746, ELAVL2, SSSCA1, BCHE, APOBEC3D, LGALS3BP, GSPT2, CSN1S1, RBM42, CDX1, RBM3, TRIM25, G3BP1, BRCA1, YAP1 |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
Tgene | FAM120A | chr12:40422103 | chr9:96323391 | ENST00000375389 | + | 0 | 9 | 339_405 | -9 | 629 | YES1%2C SRC and FYN |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Tgene | FAM120A | chr12:40422103 | chr9:96323391 | ENST00000277165 | + | 14 | 18 | 339_405 | 935 | 1119 | YES1%2C SRC and FYN |
Tgene | FAM120A | chr12:40422103 | chr9:96323391 | ENST00000333936 | + | 15 | 19 | 339_405 | 963 | 1147 | YES1%2C SRC and FYN |
Tgene | FAM120A | chr12:40422103 | chr9:96323391 | ENST00000340893 | + | 13 | 17 | 339_405 | 889 | 1073 | YES1%2C SRC and FYN |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for SLC2A13_FAM120A |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for SLC2A13_FAM120A |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | SLC2A13 | C0236969 | Substance-Related Disorders | 1 | CTD_human |